loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

Technical details about Ganciclovir Sodium, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 107910-75-8, Ganciclovir sodium salt, Cytovene iv, Rs-21592 sodium, Ganciclovir (sodium), Ganciclovir sodium [usan]
Molecular Formula
C9H12N5NaO4
Molecular Weight
277.21  g/mol
InChI Key
JJICLMJFIKGAAU-UHFFFAOYSA-M

An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)purin-6-olate
2.1.2 InChI
InChI=1S/C9H13N5O4.Na/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16;/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17);/q;+1/p-1
2.1.3 InChI Key
JJICLMJFIKGAAU-UHFFFAOYSA-M
2.1.4 Canonical SMILES
C1=NC2=C(N1COC(CO)CO)N=C(N=C2[O-])N.[Na+]
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Biolf-62

2. Bw-759

3. Cytovene

4. Ganciclovir

5. Ganciclovir, Monosodium Salt

6. Gancyclovir

7. Rs-21592

2.2.2 Depositor-Supplied Synonyms

1. 107910-75-8

2. Ganciclovir Sodium Salt

3. Cytovene Iv

4. Rs-21592 Sodium

5. Ganciclovir (sodium)

6. Ganciclovir Sodium [usan]

7. 84245-13-6

8. Sodium;2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)purin-6-olate

9. 107910-75-8 (sodium)

10. Ganciclovir Sodium (usan)

11. Natclovir

12. Cytovene-iv

13. 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, Monosodium Salt

14. Rs 21592 Sodium

15. 02l083w284

16. Unii-02l083w284

17. Cytovene Iv Sodium

18. Ganciclovir Sodium (unspecified Mf)

19. Cytovene Iv (tn)

20. Ganciclovir (as Sodium)

21. 6h-purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-, Monosodium Salt

22. Schembl149822

23. Chembl1200850

24. Dtxsid20883175

25. Hy-13637a

26. Mfcd00873979

27. Akos015896059

28. Bs-1004

29. Ccg-267214

30. Sodium 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6h-purin-6-one

31. Db-059667

32. Cs-0013616

33. Ft-0656038

34. D04301

35. J-002034

36. Q27231533

37. Sodium 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9h-purin-6-olate

38. 2-amino-1,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6h-purin-6-one Sodium Salt

39. 6h-purin-6-one, 1,9-dihydro-2-amino-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-, Monosodium Salt

40. 6h-purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-, Sodium Salt

2.3 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 277.21 g/mol
Molecular Formula C9H12N5NaO4
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count5
Exact Mass277.07869816 g/mol
Monoisotopic Mass277.07869816 g/mol
Topological Polar Surface Area142 Ų
Heavy Atom Count19
Formal Charge0
Complexity273
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 3  
Drug NameGANCICLOVIR SODIUM
Active IngredientGANCICLOVIR SODIUM
CompanyPHARMASCIENCE INC (Application Number: A207645)

2 of 3  
Drug NameGANCICLOVIR
Active IngredientGANCICLOVIR SODIUM
CompanyFRESENIUS KABI USA (Application Number: A090658); LUITPOLD PHARMS INC (Application Number: A202624); MYLAN LABS LTD (Application Number: A204560); PAR STERILE PRODUCTS (Application Number: A204950)

3 of 3  
Drug NameCYTOVENE
Active IngredientGANCICLOVIR SODIUM
CompanyROCHE PALO (Application Number: N019661)

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
DNA Polymerase Inhibitors [MoA]; Nucleoside Analog Antiviral [EPC]; Nucleoside Analog [EXT]; Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
Post Enquiry
POST ENQUIRY